🇺🇸 Pascoflair in United States

37 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 37

Most-reported reactions

1. Polydactyly — 7 reports (18.92%)
2. Foetal Exposure During Pregnancy — 6 reports (16.22%)
3. Asthenia — 3 reports (8.11%)
4. Blood Alkaline Phosphatase Increased — 3 reports (8.11%)
5. Blood Lactate Dehydrogenase Increased — 3 reports (8.11%)
6. Gamma-Glutamyltransferase Increased — 3 reports (8.11%)
7. Nocturia — 3 reports (8.11%)
8. Off Label Use — 3 reports (8.11%)
9. Thrombocytopenia — 3 reports (8.11%)
10. Tonic Convulsion — 3 reports (8.11%)

Source database →

Frequently asked questions

Is Pascoflair approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pascoflair in United States?

Pascoe Pharmazeutische Praeparate GmbH is the originator. The local marketing authorisation holder may differ — check the official source linked above.